Francisco Quinteros, MD
Colon & Rectal Surgery · Chicago, ILNPI 1427206689
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,129 of the $118,829 with a category attached, or 75.0%. 20 manufacturers reported payments, led by Applied Medical Resources Corporation at 35.5% of the total. Among colon & rectal surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $521.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$42K
- Medtronic$34K
- Covidien LP$22K
- THD America, Inc.$14K
- Ferring Pharmaceuticals Inc.$4K
- Intuitive Surgical$1K
- plus $3K from 14 others
What the payments were for
- Consulting fees$9,9388%
- Speaking & faculty fees$89,12975%
- Travel & lodging$11,60410%
- Food & beverage$8,0797%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 50 | $42,129 |
| Medtronic | 90 | $33,584 |
| Covidien LP | 25 | $21,565 |
| THD America, Inc. | 30 | $13,909 |
| Ferring Pharmaceuticals Inc. | 1 | $3,600 |
| Intuitive Surgical | 7 | $1,298 |
| Davol Inc. | 4 | $924 |
| W. L. Gore & Associates, Inc. | 7 | $665 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $400 |
| LSI Solutions Inc | 1 | $125 |
| GSK | 1 | $125 |
| TELA Bio, Inc. | 1 | $120 |
| Kerecis Limited | 1 | $102 |
| Innovation Technologies Inc | 2 | $83 |
| Conmed Corporation | 1 | $76 |
| Braintree Laboratories, Inc. | 2 | $34 |
| Novo Nordisk | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gelport Laparoscopic System$17,712
- GELPOINT PATH$9,881
- GELPOINT Path Transanal Procedural Pack$7,707
- Signia$5,932
- GelPOINT Path Transanal Access Platform$3,207
- LigaSure$2,700
- ILLUMISITE$2,475
- EEA$1,200
- Da Vinci Surgical System$1,199
- GelPOINT V-Path$752
- EleVision$578
- ProGrip$485
- Surgical wound closure product$400
- AbsorbaTack$354
- VS3 IRIDIUM - FLUORESCENCE HIGH DEFINITION CAMERA (CAMERA-IR)$292
- Sonicision$261
- ALEXIS Orthopaedic Protector$241
- SEAMGUARD Bioabsorbable Staple Line Reinforcement$166
- Tacker$165
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$150
How this compares
$118,829 in reported general payments places this provider in the 95th percentile of 79 colon & rectal surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 15 | $2,433 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 26 | $1,703 |
| Neomycin Sulfate | 28 | $159 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $133 |
| Doxycycline Hyclate | 12 | $121 |
| Ibuprofen | 35 | $102 |
| Metronidazole | 29 | $52 |
| Tramadol Hcl | 19 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $34 | $2,43315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 79 colon & rectal surgery providers in Illinois.
Other colon & rectal surgery in Chicago
- Marc SingerChicago$201K
- Konstantin UmanskiyChicago$30K
- Vitaliy PoylinChicago$26K
- Neil HymanChicago$20K
- Amy HalversonChicago$19K
- Gerald GanttChicago$16K
- Jacqueline HarrisonChicago$15K
- Scott StrongChicago$12K
- Steven StrykerChicago$11K
- Anders MellgrenChicago$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.